Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|June 2, 2021
Leapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in RwandaPaula Mc Kenna, Serge Masyn, Annik Willems, et al.Journal of the International AIDS Society|October 1, 2020
HIV infection and engagement in HIV care cascade among men who have sex with men and transgender women in Kigali, Rwanda: a cross-sectional studyJean Olivier Twahirwa Rwema, Carrie E Lyons, Sara Herbst, et al.The Journal of Infectious Diseases|July 1, 2022
Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination CampaignJulien Nyombayire, Rosine Ingabire, Ben Magod, et al.Plos Medicine|February 11, 2025
Contraception use and pregnancy in women receiving a 2-dose Ebola vaccine in Rwanda: A retrospective analysis of UMURINZI vaccination campaign dataRosine Ingabire, Julien Nyombayire, Amelia Mazzei, et al.Trials|June 20, 2022
Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trialEtienne Karita, Julien Nyombayire, Rosine Ingabire, et al.Nature Medicine|September 8, 2025
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trialJulien Nyombayire, Rosine Ingabire, Amelia Mazzei, et al.NPJ Vaccines|August 1, 2025
How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreakSabin Nsanzimana, Noella Bigirimana, Richard Hatchett, et al.Plos One|August 8, 2015
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African AdultsJuliet Mpendo, Gaudensia Mutua, Julien Nyombayire, et al.Vaccines|July 27, 2026
Implementation of a Large-Scale Ebola Vaccination Campaign in RwandaRosine Ingabire, Julien Nyombayire, Felix Sayinzoga, et al.Human Vaccines & Immunotherapeutics|December 31, 2013
Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in AfricaClaudia Schmidt, Walter Jaoko, Gloria Omosa-Manyonyi, et al.Pageof 4